BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19472094)

  • 21. [Single cell--definitive diagnosis! Where the profession ends and the art begins?].
    Kardum-Skelin I; Fabijanić I; Jelić-Puskarić B; Siftar Z; Kardum Paro MM; Trcić RL; Mahovlić V; Kusec R; Seili-Bekafigo I
    Acta Med Croatica; 2008 Oct; 62(4):343-9. PubMed ID: 19205411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory diagnosis of acute myeloid leukaemia.
    Swirsky DM; Richards SJ
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):1-17. PubMed ID: 11355921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnostics of malignant disorders.
    Rose MG; Degar BA; Berliner N
    Clin Adv Hematol Oncol; 2004 Oct; 2(10):650-60. PubMed ID: 16163252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling as a diagnostic tool in acute myeloid leukemia.
    Kern W; Kohlmann A; Schnittger S; Hiddemann W; Schoch C; Haferlach T
    Am J Pharmacogenomics; 2004; 4(4):225-37. PubMed ID: 15287816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multiparametric scanning system for evaluation of minimal residual disease in hematological malignancies.
    Trakhtenbrot L; Rechavi G; Amariglio N
    Acta Haematol; 2004; 112(1-2):24-9. PubMed ID: 15179001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Minimal residual disease in malignant diseases of the blood I. Background and pre-clinical validation].
    Hokland P; Nyvold CG; Stentoft J; Ommen HB; Ebbesen LH; Braendstrup K; Andersen BL; Mikkelsen LS; Ostergaard M
    Ugeskr Laeger; 2009 Jan; 171(4):229-31. PubMed ID: 19174037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular diagnosis of hematopoietic and lymphoid neoplasms.
    Jevremovic D; Viswanatha DS
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):903-33. PubMed ID: 19577174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multifaceted approach to diagnosis and classification of acute leukemia.
    McKenna RW
    Arch Pathol Lab Med; 1991 Apr; 115(4):328-30. PubMed ID: 2012493
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetics for the diagnosis and treatment of mesenchymal tumors.
    Lasota J; Fanburg-Smith JC
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):215-30. PubMed ID: 18260032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer and leukemia group B leukemia correlative science committee: major accomplishments and future directions.
    Bloomfield CD; Mrózek K; Caligiuri MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3564s-71s. PubMed ID: 16740786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia diagnosis: today and tomorrow.
    Béné MC; Grimwade D; Haferlach C; Haferlach T; Zini G;
    Eur J Haematol; 2015 Oct; 95(4):365-73. PubMed ID: 26110830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Minimal residual disease in hematology].
    Rák K
    Orv Hetil; 2001 May; 142(21):1091-5. PubMed ID: 11449837
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular techniques in cytopathology practice.
    Schmitt FC; Longatto-Filho A; Valent A; Vielh P
    J Clin Pathol; 2008 Mar; 61(3):258-67. PubMed ID: 18037664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic, fluorescence in situ hybridization, and molecular characterization of chronic myeloid leukemia in chronic phase with four BCR/ABL1 fusion signals: a case report.
    Vargas MT; Portero MA; Rodríguez A; Reyes J; Fernández-Novoa C
    Cancer Genet Cytogenet; 2009 Nov; 195(1):71-4. PubMed ID: 19837272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunophenotyping in diagnostic and classification of leukemia].
    Dimitrijević H; Kamenov B; Milenović D; Kostić G; Vojinović J
    Srp Arh Celok Lek; 1994; 122 Suppl 1():108-10. PubMed ID: 18173208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of integrating clinical and genetic information.
    Dugas M; Schoch C; Schnittger S; Kohlmann A; Kern W; Haferlach T; Uberla K
    In Silico Biol; 2002; 2(3):383-91. PubMed ID: 12542421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic analysis and immunophenotyping in the diagnosis of hematological disease].
    Hergersberg M; Röthlisberger B; Heijnen IA; Huber AR
    Ther Umsch; 2004 Feb; 61(2):83-91. PubMed ID: 15018391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current treatment of acute leukemias in adults].
    Elonen E
    Duodecim; 2014; 130(3):221-30. PubMed ID: 24660381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathology in the diagnosis of hematologic neoplasia. Review article.
    Sambade C; Sällström JF; Sundström C
    APMIS; 1997 Dec; 105(12):895-903. PubMed ID: 9463507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal residual disease: current status in leukemia.
    Stock W
    Clin Adv Hematol Oncol; 2003 Apr; 1(4):210-1. PubMed ID: 16224407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.